Kinaneh Safa, Agbaria Mohammad, Abu-Saleh Niroz, Hamoud Shadi
Department of Physiology, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Department of Internal Medicine A, Rambam Health Care Campus, Haifa, Israel.
Data Brief. 2018 Sep 6;20:1305-1308. doi: 10.1016/j.dib.2018.08.179. eCollection 2018 Oct.
This data article contains analysis of data observed in E mice placed on high fat diet, and treated by intraperitoneal injections of either normal saline (control) or the heparanase inhibitor PG545, in two different doses. Mice body weights and food intake were measured weekly and analyzed data are presented in graphs. Data will be of value for further understanding the role of the enzyme heparanase in controlling food intake and body weight. For further interpretations, see please "Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E mice" (Muhammad et al. 2018).
本数据文章包含对高脂饮食的E小鼠的数据分析，这些小鼠通过腹腔注射两种不同剂量的生理盐水（对照）或乙酰肝素酶抑制剂PG545进行处理。每周测量小鼠体重和食物摄入量，并以图表形式呈现分析数据。这些数据对于进一步了解乙酰肝素酶在控制食物摄入量和体重方面的作用具有重要价值。如需进一步解读，请参阅《乙酰肝素酶抑制减轻E小鼠的动脉粥样硬化进展和肝脏脂肪变性》（穆罕默德等人，2018年）。
